ATCC® Peripheral Blood Mononuclear Cell (PBMC) provides a physiologically relevant mix of immune cells — ideal for modeling immune responses, screening immunomodulatory compounds, and evaluating off-target effects in preclinical studies between leading drug, vaccine, and cell therapy developers. Learn more about ATCC® PBMCs at Link